Cambio de color arlequín en un neonato positivo a COVID-19: Reporte de caso

Esther Pinel-Guzmán; Julian Martínez-Fernandez; Rafael Pinel-Dubón; Olman Gradis-Santos; Mario Santamaría-Vásquez

doi:10.35663/amp.2023.401.2177

Esther Pinel-Guzmán School of Medicine, Universidad Católica de Honduras, Tegucigalpa – Honduras. https://orcid.org/0000-0001-9848-1014
Julian Martínez-Fernandez School of Medicine, Universidad Católica de Honduras, Tegucigalpa – Honduras. https://orcid.org/0000-0003-4091-3093
Rafael Pinel-Dubón PICU, Hospital General del Sur, Choluteca – Honduras. https://orcid.org/0000-0002-1602-1207
Olman Gradis-Santos School of Medicine, Universidad Católica de Honduras, Tegucigalpa – Honduras. https://orcid.org/0000-0001-7403-4156
Mario Santamaría-Vásquez School of Medicine, Universidad Católica de Honduras, Tegucigalpa – Honduras https://orcid.org/0000-0003-4910-0136

DOI: https://doi.org/10.35663/amp.2023.401.2177

Keywords: Coronavirus Infections, COVID-19, Newborn, Harlequin syndrome, Pediatrics, Skin Manifestations

Abstract

Harlequin color change is a benign, idiopathic, self-limiting disorder characterized by the appearance of skin divided into two distinctly colored areas. Its etiology is unknown but thought to be caused by immaturity of hypothalamic regulation of peripheral vascular tone. COVID-19 infection in neonates is infrequent and rarely symptomatic, with only a few cases described in the literature. In isolation, both conditions have a low incidence. It is the first case reported in the world literature of harlequin color change in a newborn who tested positive for COVID-19. There isn’t a single publication that links harlequin color change to COVID-19.

Downloads

Download data is not yet available.

Harlequin color change in a newborn who was positive for COVID-19: report of a case

Abstract

Downloads